Researchers at the Weizmann Institute in Israel have developed an AI-powered pipeline to predict how natural toxins interact with proteins. This innovative approach combines artificial intelligence with traditional research methods, unlocking new possibilities in drug development and ecological studies. The focus is on a cone snail toxin, Conkunitzin-S1, which immobilizes fish by blocking potassium channels.
The scientists utilized AI tools like AlphaFold and ET3 to identify the specific potassium channels targeted by the toxin. This breakthrough not only enhances understanding of the toxin's effects but also paves the way for developing safer drugs by accurately identifying molecular targets. The implications extend to ecological conservation, as the research can help predict the impact of toxins on various species.
• AI tools enhance understanding of natural toxins and their biological interactions.
• The research aims to develop safer drugs by identifying precise molecular targets.
AlphaFold is an AI program used to predict protein structures, aiding in understanding toxin interactions.
ET3 is an AI model developed to analyze molecular dynamics around potassium channels.
The Weizmann Institute is a research organization that developed an AI pipeline for drug discovery.
The Brighterside of News on MSN.com 5month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.